GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (OTCPK:IUGNF) » Definitions » Accumulated Depreciation

IUGNF (Imugene) Accumulated Depreciation : $0.00 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Imugene Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Imugene's quarterly accumulated depreciation increased from Dec. 2023 ($0.00 Mil) to Jun. 2024 ($-0.62 Mil) but then stayed the same from Jun. 2024 ($-0.62 Mil) to Dec. 2024 ($0.00 Mil).

Imugene's annual accumulated depreciation declined from Jun. 2022 ($-0.30 Mil) to Jun. 2023 ($-0.23 Mil) but then increased from Jun. 2023 ($-0.23 Mil) to Jun. 2024 ($-0.62 Mil).


Imugene Accumulated Depreciation Historical Data

The historical data trend for Imugene's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imugene Accumulated Depreciation Chart

Imugene Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.10 -0.19 -0.30 -0.23 -0.62

Imugene Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.23 - -0.62 -

Imugene Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Imugene Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Imugene's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Imugene Business Description

Traded in Other Exchanges
Address
4-6 Bligh Street, Suite 12.01, Level 12, Sydney, NSW, AUS, 2000
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its products include HER-Vaxx, PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment is the Research and Development of oncolytic immunotherapies.